BEDFORD Mass. – May 26, 2021 – Verseau Therapeutics, Inc. today announced the appointment of
John Edwards as Chief Executive Officer. John brings over 30 years of biopharmaceutical leadership
experience and has been involved in the discovery, development or global commercialization of 10 FDA approved biologics and eight biotech companies with successful exits.
WATERTOWN, Mass.–(BUSINESS WIRE)– SQZ Biotechnologies Company (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, will present safety and tolerability, manufacturing, and antitumor activity data from its ongoing Phase 1 clinical trial of SQZ-PBMC-HPV-101 in patients with advanced or metastatic Human Papillomavirus Positive tumors at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 4-8.
NEW YORK – Variantyx, a genetic testing company offering clinical whole-genome sequencing-based
assays, is expanding its menu to include prenatal and pan-cancer testing in the US.
The firm’s Genomic Unity Prenatal Analysis test, to be used when an ultrasound identifies structural
anomalies in a fetus, launched in January and will be available by the end of the second quarter. The
test analyzes amniotic fluid as well as blood from both parents to provide a genomic analysis of the
fetus.
WATERTOWN, Mass.–(BUSINESS WIRE)– SQZ Biotechnologies Company (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today reported financial results for the period ended March 31, 2021 and reviewed recent business highlights.
WATERTOWN, Mass.–(BUSINESS WIRE)– SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, announced today that it will present new data on the company’s scaled cGMP cell therapy manufacturing program at the 2021 American Society for Gene and Cell Therapy Virtual Annual Meeting (ASGCT) from May 11-14. The company will also present findings on the performance advantages of cells engineered through its proprietary Cell Squeeze® Technology.